Masato Iwabu

5.5k total citations · 1 hit paper
37 papers, 2.0k citations indexed

About

Masato Iwabu is a scholar working on Epidemiology, Physiology and Molecular Biology. According to data from OpenAlex, Masato Iwabu has authored 37 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 18 papers in Physiology and 10 papers in Molecular Biology. Recurrent topics in Masato Iwabu's work include Adipokines, Inflammation, and Metabolic Diseases (21 papers), Adipose Tissue and Metabolism (17 papers) and Regulation of Appetite and Obesity (7 papers). Masato Iwabu is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (21 papers), Adipose Tissue and Metabolism (17 papers) and Regulation of Appetite and Obesity (7 papers). Masato Iwabu collaborates with scholars based in Japan, South Korea and Spain. Masato Iwabu's co-authors include Toshimasa Yamauchi, Takashi Kadowaki, Miki Okada‐Iwabu, Kohjiro Ueki, Shigeyuki Yokoyama, Mikako Shirouzu, Hiroaki Tanabe, Kumpei Tokuyama, Ken‐ichi Hamagami and Koichi Matsuda and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Masato Iwabu

35 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity

2013 598 citations Miki Okada‐Iwabu, Toshimasa Yamauchi et al. Nature profile →

Peers

Countries citing papers authored by Masato Iwabu

Since Specialization

Citations

This map shows the geographic impact of Masato Iwabu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masato Iwabu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masato Iwabu more than expected).

Fields of papers citing papers by Masato Iwabu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masato Iwabu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masato Iwabu. The network helps show where Masato Iwabu may publish in the future.

Co-authorship network of co-authors of Masato Iwabu

This figure shows the co-authorship network connecting the top 25 collaborators of Masato Iwabu. A scholar is included among the top collaborators of Masato Iwabu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masato Iwabu. Masato Iwabu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Case of Adrenocorticotropin-dependent Cushing Syndrome with Osilodrostat Exposure in Early Pregnancy 2025 ·JCEM Case Reports ·(unknown), (unknown), (unknown), Yoshio Shima, Shigeyuki Tahara, Masato Iwabu	0
2	A monoclonal antibody activating AdipoR for type 2 diabetes and nonalcoholic steatohepatitis 2023 ·Science Advances ·(unknown), Miki Okada‐Iwabu, Masato Iwabu, Kouichi Wada, (unknown), Toshimasa Yamauchi, Takashi Kadowaki	11
3	A Case of Hepatitis E Virus Infection: One of Differential Diagnosis of Liver Injury in Patients Undergoing Peritoneal Dialysis 2022 ·International Medical Case Reports Journal ·(unknown), Yukinao Sakai, (unknown), (unknown), (unknown), Tetsuya Kashiwagi, Masato Iwabu	0
4	Concomitant Anti-GBM Glomerulonephritis and Acute Interstitial Nephritis Following Programmed Death Receptor-1 Blockade With Nivolumab 2022 ·Kidney International Reports ·Takashi Tani, (unknown), Kazumasa Hashimoto, Akiko Mii, Tetsuya Kashiwagi, Akira Shimizu, Yukinao Sakai, Masato Iwabu	4
5	Patient motivation to lose weight: Importance of healthcare professional support, goals and self-efficacy 2021 ·European Journal of Internal Medicine ·Dror Dicker, Assim A. Alfadda, Walmir Coutinho, Ada Cuevas, Jason C. G. Halford, Carly A. Hughes, Masato Iwabu, Jae‐Heon Kang, Rita Nawar, (unknown), Nicolai A. Rhee, Georgia Rigas, Javier Salvador, Paolo Sbraccia, Verónica Vázquez‐Velázquez, Ian D. Caterson	27
6	The 3Ds – Discussion, diagnosis and direction: Elements for effective obesity care by healthcare professionals 2021 ·European Journal of Internal Medicine ·Assim A. Alfadda, Ian D. Caterson, Walmir Coutinho, Ada Cuevas, Dror Dicker, Jason C. G. Halford, Carly A. Hughes, Masato Iwabu, Jae‐Heon Kang, Rita Nawar, (unknown), Nicolai A. Rhee, Georgia Rigas, Javier Salvador, Verónica Vázquez‐Velázquez, Paolo Sbraccia	1
7	Diagnostic prediction of COVID-19 based on clinical and radiological findings in a relatively low COVID-19 prevalence area 2021 ·Respiratory Investigation ·Yosuke Amano, Hidenori Kage, Goh Tanaka, Wataru Gonoi, Yudai Nakai, Ryo Kurokawa, Shohei Inui, Koh Okamoto, Sohei Harada, Masato Iwabu, (unknown), Osamu Abe, Kyoji Moriya, Takahide Nagase	5
8	Human adiponectin receptor AdipoR1 assumes closed and open structures 2020 ·Communications Biology ·Hiroaki Tanabe, Yoshifumi Fujii, Miki Okada‐Iwabu, Masato Iwabu, Kuniyuki Kano, Hiroki Kawana, Masakatsu Hato, Yoshihiro Nakamura, Takaho Terada, (unknown), Mikako Shirouzu, Yoshiaki Kawano, Masaki Yamamoto, Junken Aoki, Toshimasa Yamauchi, Takashi Kadowaki, Shigeyuki Yokoyama	18
9	Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19 2020 ·Frontiers in Cardiovascular Medicine ·(unknown), Masato Iwabu, Miki Okada‐Iwabu, Koh Okamoto, Yosuke Amano, (unknown), Takashi Kadowaki, Toshimasa Yamauchi	3
10	Adiponectin/AdipoR Research and Its Implications for Lifestyle-Related Diseases 2019 ·Frontiers in Cardiovascular Medicine ·Masato Iwabu, Miki Okada‐Iwabu, Toshimasa Yamauchi, Takashi Kadowaki	55
11	Adiponectin/adiponectin receptor in disease and aging 2015 ·PubMed ·Masato Iwabu, Miki Okada‐Iwabu, Toshimasa Yamauchi, Takashi Kadowaki	75
12	A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity breakdown → 2013 ·Nature ·Miki Okada‐Iwabu, Toshimasa Yamauchi, Masato Iwabu, Teruki Honma, Ken‐ichi Hamagami, Koichi Matsuda, (unknown), Hiroaki Tanabe, (unknown), Mikako Shirouzu, Hitomi Ogata, Kumpei Tokuyama, Kohjiro Ueki, Tetsuo Nagano, Akiko Tanaka, Shigeyuki Yokoyama, Takashi Kadowaki	598
13	Adiponectin receptors: A review of their structure, function and how they work 2013 ·Best Practice & Research Clinical Endocrinology & Metabolism ·Toshimasa Yamauchi, Masato Iwabu, Miki Okada‐Iwabu, Takashi Kadowaki	270
14	Expression Levels of Adiponectin Receptors are Decreased in Human Endometrial Adenocarcinoma Tissues 2012 ·International Journal of Gynecological Pathology ·Naoko Yamauchi, Yutaka Takazawa, Daichi Maeda, Takashi Hibiya, Mariko Tanaka, Masato Iwabu, Miki Okada‐Iwabu, Toshimasa Yamauchi, Takashi Kadowaki, Masashi Fukayama	27
15	Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice 2012 ·Diabetologia ·Yasunori Nio, Toshimasa Yamauchi, Masato Iwabu, Miki Okada‐Iwabu, Masaaki Funata, Mai Yamaguchi, Kohjiro Ueki, Takashi Kadowaki	72
16	Structural basis for compound C inhibition of the human AMP-activated protein kinase α2 subunit kinase domain 2011 ·Acta Crystallographica Section D Biological Crystallography ·N. Handa, Tetsuo Takagi, Shinya Saijo, S. Kishishita, Daisuke Takaya, Marcos Hikari Toyama, Takaho Terada, Mikako Shirouzu, Atsushi Suzuki, Sai Peck Lee, Toshimasa Yamauchi, Miki Okada‐Iwabu, Masato Iwabu, Takashi Kadowaki, Yasuhiko Minokoshi, Shigeyuki Yokoyama	69
17	Global Mapping of Cell Type–Specific Open Chromatin by FAIRE-seq Reveals the Regulatory Role of the NFI Family in Adipocyte Differentiation 2011 ·PLoS Genetics ·Hironori Waki, Masahiro Nakamura, Toshimasa Yamauchi, (unknown), Jing Yu, Lisa Hirose, (unknown), Wei Sun, Masato Iwabu, Miki Okada‐Iwabu, Takanori Fujita, (unknown), Shuichi Tsutsumi, Kohjiro Ueki, Tatsuhiko Kodama, Juro Sakai, Hiroyuki Aburatani, Takashi Kadowaki	99
18	Peroxisome Proliferator-activated Receptor γ Agonist Rosiglitazone Increases Expression of Very Low Density Lipoprotein Receptor Gene in Adipocytes 2009 ·Journal of Biological Chemistry ·Takeshi Takazawa, Toshimasa Yamauchi, Atsushi Tsuchida, Makoto Takata, Yusuke Hada, Masato Iwabu, Miki Okada‐Iwabu, Kohjiro Ueki, Takashi Kadowaki	29
19	Rimonabant Ameliorates Insulin Resistance via both Adiponectin-dependent and Adiponectin-independent Pathways 2008 ·Journal of Biological Chemistry ·Taku Watanabe, Naoto Kubota, Mitsuru Ohsugi, Tetsuya Kubota, Iseki Takamoto, Masato Iwabu, Motoharu Awazawa, Hisayuki Katsuyama, Chiaki Hasegawa, Kumpei Tokuyama, Masao Moroi, Kaoru Sugi, Toshimasa Yamauchi, Tetsuo Noda, Ryozo Nagai, Yasuo Terauchi, Kazuyuki Tobe, Kohjiro Ueki, Takashi Kadowaki	40
20	5‐Hydroxytryptamine 2A receptor signaling cascade modulates adiponectin and plasminogen activator inhibitor 1 expression in adipose tissue 2008 ·FEBS Letters ·(unknown), Toshimasa Yamauchi, (unknown), Miki Okada‐Iwabu, Masato Iwabu, Kohjiro Ueki, Takashi Kadowaki	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact